The 9th Annual Translational Microbiome Conference is dedicated to the potential for translational interventions in microbiome research. The following therapeutic areas of research will be discussed:
- Obesity and Type 2 diabetes
- Women`s Health
- Immunology and the Impact of C. diffiicle Infections
- Pulmonology and COPD
- Periodontal Disease
- Dermatology
The 9th Annual Translational Microbiome Conference covers topics such as:
- The applicability of animal microbiome models to the human microbiome
- The need for standardization and harmonization of research protocols
- How the FDA will and should regulate therapeutics containing live spores
- The business model for microbiome based therapeutics
- Data needs across multiple domains
The 9th Annual Translational Microbiome Conference brings together Directors, VPs, Scientists, Heads and Professors from biotech companies, Academic Institutions, venture capitalists and pharma companies involved in:
- NGS (Next Generation Sequencing)
- Microbiome / Microbiota basic research
- Autoimmune Disease Therapeutics
- Molecular Diagnostics
- Metabolic disease, Obesity, Diabetes
- Infectious Diseases
- Genomics
- Genotyping
- Biomarkers
- Genomic Profiling
- Bioinformatics
- Immunology Innate or Adaptive Immunity
- Data Analysis
- Data Management
- Diagnostic & Clinical Applications
- Molecular Biology
- Vaccines
- Prenantal Diagnostics
- Food / Nutrition Science
- Microbiology
- Venture Capitalists
- Gut-Brain Axis Researchers
- Academic Licensing or Tech Transfer Officers
- Biotech Entrepreneurs
The 9th Annual Translational Microbiome Conference will be held in Boston, United States on 25-26 Mar 2024.
